| Title |
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
|
|---|---|
| Published in |
Advances in Rheumatology, June 2020
|
| DOI | 10.1186/s42358-020-00134-8 |
| Pubmed ID | |
| Authors |
Edgard Torres dos Reis Neto, Adriana Maria Kakehasi, Marcelo de Medeiros Pinheiro, Gilda Aparecida Ferreira, Cláudia Diniz Lopes Marques, Licia Maria Henrique da Mota, Eduardo dos Santos Paiva, Gecilmara Cristina Salviato Pileggi, Emília Inoue Sato, Ana Paula Monteiro Gomides Reis, Ricardo Machado Xavier, José Roberto Provenza |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
An error occurred while generating this chart. Please try again later.
No score history available for this output yet. Please try again later.
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 3 | 38% |
| Canada | 1 | 13% |
| India | 1 | 13% |
| France | 1 | 13% |
| Ireland | 1 | 13% |
| Unknown | 1 | 13% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Scientists | 1 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
Mendeley demographics
The data shown below were compiled from readership statistics for 330 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 330 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 10% |
| Student > Bachelor | 28 | 8% |
| Researcher | 26 | 8% |
| Other | 23 | 7% |
| Student > Doctoral Student | 20 | 6% |
| Other | 70 | 21% |
| Unknown | 129 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 102 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 5% |
| Nursing and Health Professions | 12 | 4% |
| Agricultural and Biological Sciences | 10 | 3% |
| Biochemistry, Genetics and Molecular Biology | 9 | 3% |
| Other | 49 | 15% |
| Unknown | 131 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2025.
All research outputs
#4,150,893
of 33,825,399 outputs
Outputs from Advances in Rheumatology
#39
of 250 outputs
Outputs of similar age
#82,359
of 460,310 outputs
Outputs of similar age from Advances in Rheumatology
#3
of 10 outputs
Altmetric has tracked 33,825,399 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 250 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,310 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.